H. Conti, F. Shen, N. Nayyar, E. Stocum, J. Sun et al., Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. The Journal of experimental medicine, Feb, vol.16, issue.2062, pp.299-311, 2009.

E. Glocker, A. Hennigs, M. Nabavi, A. Schaffer, C. Woellner et al., A homozygous CARD9 mutation in a family with susceptibility to fungal infections, pp.1727-1762, 2009.

B. Ferwerda, G. Ferwerda, T. Plantinga, J. Willment, A. Van-spriel et al., Human dectin-1 deficiency and mucocutaneous fungal infections. The New England journal of medicine, pp.1760-1767, 2009.
DOI : 10.1056/nejmoa0901053

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773015

C. Scully, M. Kabir, and L. Samaranayake, Candida and Oral Candidosis: A Review, Critical Reviews in Oral Biology & Medicine, vol.5, issue.2, pp.125-57, 1994.
DOI : 10.1177/10454411940050020101

N. Soysa, L. Samaranayake, and A. Ellepola, Antimicrobials as a contributory factor in oral candidosis--a brief overview. Oral diseases, pp.138-181, 2008.

C. Lass-florl, E. Gunsilius, G. Gastl, M. Englisch, G. Koch et al., Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution. Annals of hematology, pp.565-574, 2003.

J. Rex, M. Pfaller, J. Galgiani, M. Bartlett, A. Espinel-ingroff et al., Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections, Clinical Infectious Diseases, vol.24, issue.2, pp.235-282, 1997.
DOI : 10.1093/clinids/24.2.235

P. Pappas, Guidelines for Treatment of Candidiasis, Clinical Infectious Diseases, vol.38, issue.2, pp.161-89, 2004.
DOI : 10.1086/380796

W. Powderly, Clinical Perspective Oropharyngeal Candidiasis in Patients with HIV: Suggested Guidelines for Therapy, AIDS Research and Human Retroviruses, vol.15, issue.18, pp.1619-1642, 1999.
DOI : 10.1089/088922299309658

P. Yeni, Prise en charge médicale des personnes infectées par le VIH Recommandation du groupe d'experts, Flammarion. Section, vol.15, p.296, 2008.

J. Gligorov, Recommandations pour la pratique clinique: Nice ? Saint-Paul-de- Vence 2009 « cancers du sein » et « soins de support ». Partie II ? Soins de Support

R. Bensadoun, D. Daoud, L. Bastit, E. Gueddari, B. Allavena et al., Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis, Cancer, vol.4, issue.1, pp.204-211, 2008.
DOI : 10.1002/cncr.23152

C. Charlier, E. Hart, A. Lefort, P. Ribaud, F. Dromer et al., Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? The Journal of antimicrobial chemotherapy, pp.384-410, 2006.

P. Pappas, C. Kauffman, D. Andes, D. Benjamin, J. Calandra et al., Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.48, issue.5, pp.503-538, 2009.
DOI : 10.1086/596757

O. Nicolatou-galitis, A. Velegraki, A. Sotiropoulou-lontou, K. Dardoufas, V. Kouloulias et al., Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy. Support Care Cancer, pp.44-51, 2006.

J. Philpott-howard, J. Wade, G. Mufti, K. Brammer, and G. Ehninger, Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group. The Journal of antimicrobial chemotherapy, pp.973-84, 1993.

D. Havlir, M. Dube, J. Mccutchan, D. Forthal, C. Kemper et al., Prophylaxis with Weekly Versus Daily Fluconazole for Fungal Infections in Patients with AIDS, Clinical Infectious Diseases, vol.27, issue.6, pp.1369-75, 1998.
DOI : 10.1086/515018

F. Scotté, Recommandations de Saint-Paul-de-Vence Soins de support " Candidoses oropharyngées, Oncologie, vol.11, pp.682-686, 2009.